Radiesse for Nasolabial Folds | Effectiveness, Longevity, and Safety

Radiesse stimulates autologous collagen regeneration in situ through Calcium Hydroxylapatite (CaHA) microspheres, providing excellent support for deep nasolabial folds. Clinical data confirms that its effects typically last for 12-18 months. As an material, it has high safety and good biocompatibility. however, because it cannot be dissolved, it places extreme demands on the physician’s injection depth and layer. It is recommended to choose a formal medical institution and have the procedure performed by a senior expert to ensure natural results and avoid the risk of nodules.

Effectiveness

Radiesse achieves immediate filling through 30% Calcium Hydroxylapatite (CaHA) microspheres and 70% Carboxymethyl Cellulose (CMC) gel. Its G’ value (storage modulus) is as high as approximately 1400 Pa, far exceeding most hyaluronic acids, providing extremely strong compression support. Clinical data shows that after injection, it can induce the regeneration of Type I collagen and elastin fibers. At 12 months, the WSRS (Wrinkle Severity Rating Scale) score improvement rate remains at a high level.

Immediate Filling Performance

Radiesse is composed of 30% Calcium Hydroxylapatite (CaHA) microspheres and 70% Carboxymethyl Cellulose (CMC) gel carrier. Within seconds of being injected into the nasolabial fold, this semi-solid viscous implant directly fills the gaps in the deep dermis or subcutaneous tissue through physical displacement. The CMC gel provides a highly viscoelastic matrix with a viscosity typically between 300,000 to 400,000 cP, ensuring the material remains stable at the injection site without diffusing into surrounding loose tissue. The physical properties of this material determine that it can achieve a 1:1 immediate correction effect, meaning the volume of material injected results in almost an equal amount of volume lift. Unlike many Hyaluronic Acid (HA) fillers, it does not have hydrophilic expansion characteristics, so physicians do not need to over-correct during the procedure. After injection, the depth of the depression in the nasolabial fold changes immediately and visibly. The skin surface folds are smoothed by the upward pressure from the base, making the lines from the sides of the nose to the corners of the mouth smooth.

Radiesse possesses an extremely high storage modulus (G’ value), which measures the material’s ability to return to its original shape when subjected to stress. In the nasolabial fold area, where facial activity is frequent, smiling, speaking, or chewing all generate significant shear forces on the filler material. The G’ value of approximately 1400 Pa allows Radiesse to maintain its original geometric shape when subjected to these mechanical pressures, preventing it from being squeezed thin or displaced due to frequent muscle contractions. Clinical assessments usually use the WSRS (Wrinkle Severity Rating Scale) for quantification. Most individuals receiving treatment see their WSRS grade drop immediately from Grade 3 (Moderate) or Grade 4 (Severe) to Grade 1 (No wrinkles) or Grade 2 (Mild wrinkles) after injection.

During the actual procedure, Radiesse is placed at the junction of the deep dermis and the subcutaneous fat layer, or even on the periosteal surface above the piriform aperture. This deep placement utilizes the material’s high hardness to simulate the support of bone or deep fat pads. Because the microsphere diameter is distributed between 25 to 45 microns, they are very evenly distributed within the CMC gel, which ensures a smooth feel after injection without local lumps or graininess. A multicenter clinical study in North America showed that when correcting moderate to severe nasolabial folds with Radiesse, the total volume required is often about 25% less than that of mainstream hyaluronic acid fillers, reflecting its high-efficiency filling capability per unit volume. Since this filling does not rely on water absorption, the contour effect patients see upon leaving the clinic is the stable state that will be maintained for the coming weeks. This highly predictable immediate performance allows physicians to precisely sculpt facial contours, especially for patients with severe soft tissue loss and thicker skin.

Although the CMC gel is gradually engulfed and metabolized by macrophages over the following months, it plays the primary physical filling role immediately post-operation. The cohesivity of this gel is very high, ensuring that even during intense facial expressions like laughing, the filler stays close to the target tissue, maintaining natural dynamic beauty. For doctors, the physical feedback of Radiesse is strong, and the resistance during injection and the distribution path under the skin are clear and controllable. For users, this means visible signs of aging can be resolved in a single treatment session. clinical research data supports this immediacy: evaluating with the GAIS (Global Aesthetic Improvement Scale) within 30 minutes after subjects completed injection, over 98% of people were rated as “Significantly Improved” or “Very Significantly Improved”.

Tissue Regeneration

As the CMC gel carrier is metabolized by the body, the 30% Calcium Hydroxylapatite (CaHA) microspheres contained in Radiesse begin to function as biological stimulants. The diameter of these microspheres is precisely distributed between 25 to 45 microns. This size is designed to avoid phagocytosis by macrophages, and because of their smooth spherical surface, they do not cause inflammatory granulomas. As the CMC gel gradually disappears within 8 to 12 weeks after injection, the CaHA microspheres form a stable three-dimensional scaffold. Fibroblasts migrate to the surface of these microspheres and adhere, becoming activated through mechanotransduction signals. Studies show that the mechanical tension provided by this physical scaffold induces fibroblasts to transition into a synthetically active state, thereby initiating the production of endogenous collagen.

• Fibroblast Activation Mechanism: The scaffold formed on the microsphere surface allows fibroblasts to stretch. Under a microscope, stretched fibroblasts can be observed upregulating the expression of procollagen genes.
• Collagen Type Transition: Initially, mostly Type III collagen is produced, which then gradually transforms into Type I collagen, which has a firmer structure and more orderly arrangement.
• Extracellular Matrix Remodeling: In addition to collagen, fibroblasts also secrete proteoglycans and glycosaminoglycans, increasing tissue water content and elasticity.

Within 4 to 9 months after injection, histological sections show the appearance of a dense network of new collagen fibers around the CaHA microspheres. This new tissue structure is highly integrated with the body’s own connective tissue, with no obvious sense of boundary. According to a clinical biopsy study in Europe, 4 months after Radiesse injection, the collagen density in the treated area was about 30% to 50% higher than the baseline level. By the 9th month, although some CaHA microspheres begin to slowly degrade through normal calcium and phosphorus metabolic pathways, the newly generated Type I collagen has already formed a self-supporting framework.

In addition to collagen regeneration, Radiesse also promotes the production of skin elastin. Elastin is the substance that maintains skin rebound and is usually difficult to regenerate naturally after adulthood. Immunohistochemical staining analysis of the treated area found that Radiesse can induce elastin fibers to distribute in a network pattern between microspheres, a change that directly improves skin laxity in the nasolabial fold area caused by long-term pressure. Furthermore, improvement in microcirculation is also an important part of the tissue regeneration process. Around the CaHA microspheres, an increase in new microvessels can be observed, which provides fibroblasts with sufficient nutritional support and oxygen, accelerating the removal of metabolic waste, thereby making the skin surface of the nasolabial fold look healthier and more radiant, rather than just having the depression filled.

• Skin Elasticity Improvement: The regeneration of elastin fibers allows the skin to recover its original position more quickly after large facial expressions, reducing the production of dynamic wrinkles.
• Dermal Thickening Data: Ultrasound measurements show that the average dermal thickness of subjects increased by 15% to 20% after a complete course of treatment.
• Metabolic Safety: CaHA microspheres are eventually decomposed into calcium ions and phosphate, which are excreted through urine and will not leave non-degradable residues in the tissue.

For middle-aged and elderly patients aged 40 to 60, although their own collagen synthesis ability has declined, the mechanical scaffold provided by Radiesse can powerfully “wake up” residual fibroblasts. In long-term follow-up studies conducted in North America, researchers monitored patients for 52 weeks using 3D facial imaging technology. The results showed that one year after injection, even though the volume of the filler itself was decreasing, the improvement rate of the nasolabial fold remained above 80% due to the supplement of autologous tissue.

Structural Support Strength

Radiesse performs better than many traditional hyaluronic acid fillers in correcting nasolabial folds, primarily due to its extremely high storage modulus (G’). In rheological tests, the G’ value of Radiesse is usually stable at around 1400 Pa, while for common hyaluronic acid products used for filling deep wrinkles, the G’ values are mostly distributed between 200 Pa to 700 Pa. Storage modulus measures the material’s ability to maintain its shape and resist deformation when subjected to external pressure. The nasolabial fold is located in one of the most dynamic areas of the face, where smiling, chewing, and talking constantly exert vertical compression and lateral shear forces on the area. The high G’ value of Radiesse provides extremely strong physical rigidity, allowing it to act like a stable micro-scaffold, propping up skin folds collapsed due to soft tissue atrophy.

Physical parameter studies show that the firmness of Radiesse is almost 2 to 3 times that of mainstream monophasic hyaluronic acid fillers. This high-strength support allows physicians to use smaller amounts of material to achieve more significant volume lifting effects.

The viscosity of Radiesse reaches approximately 3.5 x 10^5 cP, meaning it has extremely strong cohesivity and in-situ retention capability after being injected into tissue. In a region with complex anatomical structures like the nasolabial fold, where there are many layers of subcutaneous tissue, if the material lacks sufficient viscosity, it can easily dissipate under the joint action of gravity and facial muscle movement, causing the filling effect to weaken rapidly within a few weeks post-surgery. The high viscosity characteristic of Radiesse ensures that the microsphere and gel mixture adheres tightly to the injection site. Whether placed in the deep dermis or deeper on the periosteal surface, it forms a volume mass with clear boundaries.

The deepening of nasolabial folds is often accompanied by the absorption of maxillary bone and the atrophy of deep fat pads. In a series of clinical procedures in North America, physicians often use Radiesse in a deep point injection manner, acting directly on the piriform aperture margin. At this depth, Radiesse plays the role of “artificial bone,” re-establishing deep facial support points through its hard physical properties. Since the 30% Calcium Hydroxylapatite microspheres have biological characteristics similar to human bone components, the mechanical feedback they show when compressed is very close to real hard tissue. This underlying support can fundamentally reduce the skin load above the nasolabial fold, allowing the surface skin creases to naturally flatten without the need for large amounts of filling. This structural correction from deep to shallow avoids the problems of “facial puffiness” or “obvious filling marks” that can come from filling solely under the epidermis.

Clinical imaging analysis found that 6 months after injection, the projection height loss rate of Radiesse in the nasolabial fold area was less than 15%, while some medium-viscosity fillers may lose more than 40% of height in the same period.

When the face is at rest, most fillers can maintain their basic shape, but during dynamic smiling, the mechanical balance of the material is broken. The biomechanical design of Radiesse considers this dynamic challenge. Its material structure can evenly distribute pressure from surrounding tissues, avoiding touch stiffness caused by local stress concentration. Even under strong facial muscle pull, the filled area can still maintain a smooth transition without gaps or obvious protrusions. This adaptability to dynamic pressure is due to the even distribution of CaHA microspheres in the CMC gel, forming a micro-adjustable stress network. While providing support, this network also retains necessary tissue flexibility, ensuring the user’s facial aesthetics are natural under any expression.

As the CMC gel is metabolized within 3 months after surgery, a network of new collagen fibers quickly fills the gaps between microspheres, forming a “biological hybrid structure.” This composite structure, consisting of CaHA microspheres and autologous collagen, may even exceed the pure gel filling phase in physical strength. This means that within 9 to 12 months after injection, structural support in the nasolabial fold area is provided by a composite architecture that is half artificial and half autologous. This architecture is more elastic than pure synthetic materials and can better adapt to physiological changes in facial tissue. According to long-term follow-up data from European multicenter studies, this composite support structure can still maintain over 70% of the initial correction effect at 15 months, greatly reducing the frequency of touch-ups for users to maintain their appearance.

In tests targeting patients over 50 with severe volume loss, Radiesse showed superior longitudinal lifting vectors compared to pure HA filling, effectively counteracting tissue accumulation above the nasolabial fold.

This advantage in physical parameters makes Radiesse the preferred solution for treating “severe” nasolabial folds with thicker skin and deeper wrinkles. In these cases, lightweight filling materials often cannot provide enough push to overcome the resistance of thick skin, while Radiesse, with its high G’ value of 1400 Pa and extremely high viscosity, can easily achieve structural lifting from deep to shallow layers.

Longevity

The clinical performance of Radiesse in the nasolabial fold area can typically be maintained for 12 to 18 months. Its longevity originates from the combination of 30% Calcium Hydroxylapatite (CaHA) microspheres and 70% gel carrier. In the first 3 months after injection, the gel is responsible for immediate physical support; subsequently, microspheres with a diameter of 25-45 microns induce the skin to produce Type I collagen.

Metabolic Speed Differences

When injected into the deep tissues of the nasolabial fold, the Carboxymethyl Cellulose Sodium (CMC) gel, which accounts for 70% of the total volume, begins to degrade first. This process is usually completed within 8 to 12 weeks after injection through proteolysis and macrophage phagocytic activity. The subsequent long-term support task is undertaken by the remaining 30% CaHA microspheres. These microspheres, with diameters distributed between 25 to 45 microns, form a scaffold to induce surrounding fibroblasts to secrete new Type I and Type III collagen. During this biodegradation process, the difference in metabolic speed between individuals directly determines the retention duration of the final visual effect. The body’s immune system gradually surrounds these microspheres by releasing enzymes and mobilizing phagocytes, breaking them down into calcium ions and phosphate ions. If a person’s Basal Metabolic Rate (BMR) is higher, or if the circulatory system’s ability to clear metabolic products is stronger, the erosion speed of the CaHA microsphere surface will accelerate accordingly. For example, in clinical observations of active populations aged 25 to 45, the efficient operation of the circulatory system may shorten the complete metabolic cycle of the material in the body by about 15% to 20%. The following are specific physiological and physical variables that affect the metabolism of filling substances in the nasolabial fold area:

The nasolabial fold is a high-dynamic area of the face, and approximately 15,000 muscle contractions per day exert constant mechanical stress on the filler material. This physical compression causes the originally evenly distributed CaHA microspheres to undergo minute displacements or physical wear, thereby exposing more surface area for phagocyte contact. At the biomechanical level, this constant micro-vibration environment induces a high concentration of hyaluronidase and protease in the local tissue. Although these enzymes primarily target natural tissue, they indirectly change the microenvironment around the filler, leading to fluctuations in the stability of the support structure. For users who engage in long-term High-Intensity Interval Training (HIIT) or endurance sports (such as marathons or long-distance hiking), the oxidative metabolism level in the body stays at a peak for a long time. Studies have observed that individuals who frequently participate in strenuous exercise more than 4 times per week have microcirculation blood flow in the subcutaneous tissue about 40% higher than that of sedentary people. This means the transportation channels for metabolic waste are more unobstructed, and CaHA microspheres are excreted faster after being decomposed into calcium and phosphate. The metabolic self-regulation mechanism of the human body in high-temperature environments also accelerates the softening of the gel matrix, causing its initial physical occupation volume to shrink slightly earlier. If the doctor uses deep periosteal injection (Bolus injection), the material is distributed in clumps, with a small contact area between its central region and the human tissue, receiving relatively less immune attack. This distribution pattern usually has a longer metabolic cycle than superficial scattered point injection. In contrast, when using Hyperdilute technology for facial contouring, because CaHA microspheres are diluted with a larger proportion of saline and lidocaine and spread evenly, the contact area of individual microspheres with the tissue increases significantly. Although this can more effectively induce widespread collagen proliferation, the dissolution speed of individual microspheres per unit time will also increase accordingly. Young skin has extremely high fibroblast activity. Although they can quickly generate a dense collagen fiber encapsulation around microspheres (which helps lock the position and extend the effect), the lymphatic system filtration efficiency of young bodies is also higher. In contrast, people over 50 may experience a rapid loss of feeling due to lack of tissue attachment because of the decline in endogenous collagen synthesis ability and the lack of protection by new tissue encapsulation. Therefore, in actual treatment planning, the maintenance duration span is usually marked as 12 to 18 months. This 6-month interval fluctuation is precisely to cover the complex individual metabolic differences mentioned above.

• Initial Volume Loss: There is a visible recession period 4 to 6 weeks after injection because the speed of CMC gel carrier absorption is faster than the initial speed of new collagen generation; this is not the total disappearance of the filler.
• Calcium Balance Impact: The body’s calcium-phosphorus regulation system usually does not produce global fluctuations due to trace CaHA injections, but in the local microenvironment, the ion concentration gradient induces phagocytes to continue working.
• UV Damage: UVA rays with wavelengths between 320-400nm penetrate the dermis, destroying the collagen network structure that maintains microsphere stability, directly causing the support force to collapse visually earlier.

In clinical data statistics, about 75% of users can achieve a volume retention rate of over 50% after 15 months. For metabolically active users, a micro-supplemental injection (usually only 30% of the first dose) at the 10th to 12th month can effectively extend the peak effect to around 24 months.

Filling Material Comparison

There is an essential difference in the filling logic of Radiesse and Hyaluronic Acid (HA) for nasolabial folds. This difference is first reflected in the physical parameter of elastic modulus (G’). Elastic modulus measures the ability of a material to maintain its shape and resist deformation when subjected to facial expression pressure. In North American clinical laboratory tests, the G’ value of Radiesse is usually stable at around 1400 Pa, while for most high-viscoelasticity hyaluronic acids on the market used for deep filling, G’ values are generally distributed between 200 Pa to 800 Pa. Since the nasolabial fold area is at the intersection of frequent muscle activity, the high G’ value allows Radiesse to firmly support collapsed tissue like a scaffold after injection, making it less prone to displacement or flattening due to dynamic pressures like talking or laughing. Hyaluronic acid, on the other hand, shows more of a “flexible filling” characteristic. It relies on the material’s own volume and extremely strong hydrophilicity to prop up wrinkles. its water absorption ratio can usually reach 1000 times its own volume, which provides an immediate sense of fullness but also increases the probability of local tissue swelling in the initial post-operative period.

In terms of biological interaction mechanisms, hyaluronic acid plays the role of a “temporary space filler” in the body. Once injected into the skin, it is gradually decomposed by endogenous hyaluronidase over time, with its volume decreasing linearly. Radiesse initiates a more complex biological stimulation process. When its gel matrix composed of Sodium Carboxymethyl Cellulose (CMC) is gradually absorbed during the first 3 months post-surgery, CaHA microspheres with a diameter distribution between 25 to 45 microns remain in place. According to 12-month clinical follow-up data from the United States, subjects using Radiesse still had significantly better skin thickness and firmness at the filling site after 9 months compared to their initial state, mainly due to the new collagen fiber network replacing some of the metabolized gel volume. In contrast, hyaluronic acid subjects had usually lost more than 50% of their initial filling volume at the same time point. From the perspective of user visual feedback, as an opaque white paste, the optical characteristics of Radiesse determine that it will not produce the Tyndall effect. When using hyaluronic acid to fill nasolabial folds, if the injection layer is too shallow, light passing through the transparent gel will scatter, causing a faint bluish shadow to appear on the skin surface. Radiesse completely avoids this visual risk due to its opaque physical properties and can better integrate with deep tissues. However, this also requires the injection to be precisely positioned in the deep dermis or supraperiosteal layer, as its high viscosity and opacity make it unsuitable for very superficial fine wrinkle repair.

For long-term facial appearance maintenance, Radiesse has significant advantages in lifting efficiency per unit volume. Due to its extremely high cohesivity and viscoelasticity, when counteracting moderate to severe nasolabial fold depressions, the required Radiesse injection volume to achieve the same visual lifting effect is usually 1/4 to 1/3 less than that of hyaluronic acid. This “less is more” characteristic not only reduces the sense of pressure on local tissues but also lowers the risk of the material migrating downward during facial activities. Although hyaluronic acid has the “reversibility” card in safety regulation (meaning it can be dissolved with enzyme at any time if unsatisfied), its lack of long-term structural support often forces users to increase the frequency of touch-ups, usually every 6 to 9 months. The typical maintenance cycle of Radiesse has been extended to over 15 months, and this span provides the skin with a more stable self-repair cycle. Unlike the local water retention easily caused by hyaluronic acid, the metabolic products of Radiesse are calcium ions and phosphate ions, which are substances naturally existing in the human circulatory system. In micro-section observations, the collagen induced by Radiesse is more neatly arranged. This histological improvement allows it to enhance the skin texture around the nasolabial fold while improving the fold itself. Although it cannot be “withdrawn” at any time like hyaluronic acid, its stable degradation curve and extremely low allergic reaction rate (less than 0.1%) give it a high replacement status among high-end aesthetic groups pursuing natural, long-lasting, and non-edematous effects. Hyaluronic acid focuses on moisture supplementation and dynamic adjustment, suitable for individuals trying filling for the first time and having extremely high requirements for effect reversibility; Radiesse focuses on structural remodeling and autologous regeneration, more suitable for mature users with deep nasolabial folds who wish to reduce the frequency of medical intervention and pursue a sense of bone support. In actual practice, this longevity manifests as maintaining skin mechanical performance at a relatively constant high level within 18 months after injection, avoiding the risk of volume overload caused by frequent filling.

Long-term Management Advice

For the long-term management of Radiesse in the nasolabial fold area, the primary strategy is to establish a clinical follow-up schedule based on the biodegradation cycle. Considering the metabolic curve of Calcium Hydroxylapatite (CaHA) microspheres in the body, 12 to 15 months after the first injection is the ideal window for professional assessment. At this stage, although 70% of the gel carrier has long been absorbed, the Type I collagen scaffold induced by the 30% microspheres is in a stable structural phase. According to North American clinical follow-up data, about 82% of subjects were still satisfied with the volume retention rate at 12 months. Management advice does not advocate waiting until the filler is completely metabolized before the second intervention, but rather adopting a micro-supplement strategy when the visual volume loss is about 30% to 50%.

It is recommended to schedule a professional evaluation at the 12th month after the first injection, quantifying the changes in nasolabial fold depth through 3D facial scanning to decide whether to perform preventive supplementation.

If 1.5ml of Radiesse was used initially for moderate to severe nasolabial folds, then during the maintenance period 12 to 15 months later, only 0.6ml to 0.8ml (about 40% to 50% of the initial dose) is often needed to reach the ideal volume saturation. This dose reduction effect is because the biological scaffold already formed by endogenous tissue reduces the dependence on external physical fillers. Long-term management data shows that users who perform this periodic maintenance twice in a row have an average skin thickness in the nasolabial fold area 15% to 22% higher than the untreated population. This histological gain means that as the number of treatments increases, the visual duration of a single effect will gradually extend from the initial 12 months to 18 months or even longer.

Clinical data shows that performing a second touch-up before the volume fades by 50% results in an average 30% reduction in required material, but a significant improvement in the stability of the maintenance effect.

UVA wavelengths (320-400nm) in UV rays can penetrate the dermis and activate Matrix Metalloproteinases (MMPs), which accelerate the decomposition of newly generated collagen fibers, thereby weakening the support structure around CaHA microspheres. Long-term management plans require users to use SPF 30+ broad-spectrum sunscreen daily and combine it with a skincare routine containing antioxidants (such as Vitamin C or E) to reduce the destruction of biological scaffolds by oxidative stress. In research focusing on European lifestyles, it was found that users who strictly implement sun protection measures had their filler retention performance extended by an average of 3 to 4 months compared to non-sun-protecting populations.

Long-term exposure to unprotected UV rays can increase the degradation rate of endogenous collagen by about 20%, thereby shortening the visual lifespan of Radiesse.

Nicotine reduces local blood oxygen supply by constricting microvessels, which inhibits the proliferation activity of fibroblasts, making it difficult for CaHA microspheres to trigger the maximum scale of collagen regeneration. In clinical case statistics, the maintenance time of Radiesse for long-term smokers is usually shortened to 9 to 10 months. In addition, for high-intensity athletes or those who frequently perform hot yoga or sauna, management advice explicitly mentions the risk of accelerated metabolism. Although CaHA microspheres themselves have good heat resistance, the rapid metabolism of surrounding soft tissue will accelerate the loss of the gel carrier. For this type of population, it is recommended to increase the follow-up frequency to once every 9 months to ensure that the lost volume is supplemented in time during peak metabolism periods.

Nicotine’s inhibition of microcirculation results in lower collagen regeneration efficiency, which biologically enters the recession phase 15% earlier.

The nasolabial fold is located in the high-dynamic perioral area, and approximately 15,000 muscle contractions per day exert constant pressure and shear force on Radiesse. In long-term management strategies, it is recommended to combine small amounts of botulinum toxin injection to reduce the tension of overactive muscles like the levator labii superioris, which can effectively reduce the damage of physical wear to the filled structure. This combined therapy of “biological stimulation + power reduction” has been proven in European and American clinics to push the ideal maintenance time of Radiesse from 15 months to a high of 21 months.

Reducing the mechanical squeeze of facial muscles can significantly protect the physical distribution of CaHA microspheres, preventing them from minute displacements or excessive wear in high-dynamic areas.

The advantage of Radiesse lies in the fact that it is not just a filler, but also an improvement of skin texture. During a management cycle of up to 2 years, users will find that the elastic modulus of the skin around the nasolabial fold has improved because the new collagen has enhanced the mechanical strength of the dermis. It is recommended to conduct a skin elasticity test every six months during the management process. If tissue firmness is found to be improved, the interval between subsequent injections can be appropriately extended.

The endogenous tissue repair induced by Radiesse can still be detected 18 months after injection, providing a solid physiological basis for reducing the frequency of subsequent medical interventions.

Safety

Radiesse primarily consists of 30% Calcium Hydroxylapatite (CaHA) microspheres (25-45 microns in diameter) and 70% Carboxymethyl Cellulose (CMC) gel. In 2006, it passed approval for the correction of nasolabial folds. Clinical data shows that its non-immunogenic characteristics result in a hypersensitivity reaction rate of less than 0.1%, with no pre-operative skin test required. Common reactions such as edema (incidence ≈ 13%) and bruising (≈ 11%) usually disappear within 7 days, and the clinical report rate for serious complications like granulomas is below 1%.

Naturally Compatible Components

The composition ratio of Radiesse is fixed at 30% Calcium Hydroxylapatite (CaHA) microspheres and 70% Carboxymethyl Cellulose (CMC) gel carrier. The chemical formula of CaHA is Ca₁₀(PO₄)₆(OH)₂, a mineral composition completely consistent with the inorganic components in human bones and teeth. Because it is produced synthetically and does not contain any protein components of bovine, porcine, or human origin, it largely avoids immune reactions induced by foreign proteins. Clinical observations show that no skin allergy test is required before using the product, and its non-immunogenic characteristics mean the human body does not recognize it as a foreign object to be immediately rejected upon contact. The diameter of CaHA microspheres is precisely engineered to be strictly controlled between 25 microns and 45 microns. The surface of the microspheres exhibits a high degree of smoothness and perfect sphericity, which reduces friction and inflammatory reactions with surrounding tissues. The size of the particle directly affects the distribution and metabolic path of the preparation within the tissue:

• Particle size > 20 microns: Effectively prevents microspheres from being engulfed by macrophages and migrating through the lymphatic system in the early stages, ensuring the filler stays stable at the injection site.
• Particle size < 60 microns: Ensures the preparation can pass smoothly through 27G or 28G fine injection without blocking or being squeezed out of shape during the operation.
• Spherical surface: Smooth particle boundaries do not induce abnormal proliferation of fibroblasts but rather guide them toward orderly physiological collagen deposition.

After injection into the deep tissue of the nasolabial fold, the 70% CMC gel carrier first plays a physical space-occupying role. This gel, consisting of water, glycerin, and Sodium Carboxymethyl Cellulose, has good tissue diffusibility. Within 8 to 12 weeks after injection, the CMC gel is gradually degraded by enzymes in the human tissue and eventually excreted through normal metabolic pathways. As the gel carrier disappears, the 30% CaHA microspheres remain in situ in the tissue gaps, forming a temporary biological scaffold. This scaffold provides a physical basis for the migration and attachment of fibroblasts. Fibroblasts are stimulated by mechanical tension on the microsphere surface, becoming activated and beginning to secrete endogenous Type I Collagen and elastin. The biodegradation of CaHA microspheres follows a physiological ionization path:

1. Macrophage encapsulation: After the CMC gel is absorbed, local macrophages surround the CaHA microspheres, forming a stable microenvironment on the microsphere surface.
2. Acidic dissolution: Macrophages slowly strip calcium and phosphate ions from the microsphere surface by secreting acidic substances and enzymes.
3. Natural metabolism: The decomposed calcium ions (Ca²⁺) and phosphate (PO₄³⁻) enter the human circulatory system.
4. Renal excretion: These ions participate in the normal mineral metabolism cycle of the human body, with the excess excreted by the kidneys through urine.

This component exhibits an extremely high G’ (storage modulus) in physical performance, with values usually maintained around 1400 Pa. In comparison, the G’ values of common large-molecule hyaluronic acids on the market are usually between 500 Pa to 700 Pa. A high G’ value indicates that Radiesse has extremely strong resistance to deformation and support force. In the nasolabial fold area, which is frequently squeezed by facial expression muscles, it can maintain shape stability and will not easily migrate to surrounding tissues. Because it does not have the hydrophilic expansion characteristics of hyaluronic acid, the immediate post-operative effect is highly consistent with the long-term effect, reducing visual errors caused by local edema from water absorption. In clinical follow-up data spanning over 52 weeks, CaHA microspheres showed excellent in-situ stability.

• Tissue integration: Due to the mineral properties of its components, new tissue grows closely around the microspheres, making the touch of the filled area closer to natural skin tissue.
• Controllable decomposition: The shrinking of the microsphere diameter from 45 microns to disappearance is an extremely slow process, which ensures a smooth transition of volume support.
• Blood compatibility: Laboratory testing data proves that CaHA does not interfere with normal coagulation mechanisms or induce local microthrombi.

Clinical Feedback

In a random, controlled, double-blind study initially submitted to the, involving 117 subjects over 6 months, researchers used a split-face comparison method to compare Radiesse with traditional collagen fillers. Data showed that at the 6th month after injection, 82% of subjects showed significant improvement on the WSRS scale, while the improvement rate in the control group was only 40%. Subsequent long-term follow-up studies showed that 12 months after injection, 78% of subjects still maintained the initial correction effect. The clinical trial detailed the diary feedback of subjects within 14 days post-surgery, revealing the distribution of short-term adverse reactions. Most reactions naturally subside within 3 to 7 days.

A multicenter, large-scale retrospective study in North America analyzed over 1000 patients who received nasolabial fold filling. Feedback showed that doctors adding 2% Lidocaine during the procedure (usually 0.26ml lidocaine mixed with 1.5ml preparation) significantly improved comfort, reducing pain scores from 6.8 to 1.2 (out of 10 points). In-depth safety feedback focused on the probability of long-term nodules. After following these patients for 24 months, the clinically reported incidence of nodules was below 0.1%. To more intuitively understand the post-operative recovery process, the following table shows the symptom evolution at different time points in clinical feedback:

In studies of subjects with Fitzpatrick skin types IV to VI (darker skin), Radiesse showed excellent safety, with no clinical cases of hypertrophic scarring, hyperpigmentation, or hypopigmentation observed. This is of great significance for populations with darker skin tones, as such individuals usually face a higher risk of post-inflammatory hyperpigmentation when undergoing invasive skin procedures. This data supports the physical stability of CaHA microspheres when injected deep into the skin, proving they do not induce intense dermal melanocyte activation. Feedback from the Global Aesthetic Improvement Scale (GAIS) further quantified visual success rates. In a clinical observation involving 400 patients in Europe, GAIS scores 3 months after injection showed that 98% of patients were rated as “Improved” or “Significantly Improved” by doctors. In patient self-assessments, the approval rate for firmness improvement in the nasolabial fold area reached 95%. The most frequently mentioned positive comments in the feedback were “natural appearance” and “realistic touch,” which were attributed to the high integration of collagen induced by CaHA microspheres with the natural surrounding tissue, avoiding the “puffiness” or “plasticky feel” that some fillers might produce. In tens of millions of injection records globally, the incidence of vascular embolism is at a statistically very low level, and most such cases were attributed to injection technique errors rather than product component defects. Clinical advice to use a 22G or 25G Blunt () for fan-shaped injection can further reduce the risk of local vascular injury by more than 70%.

Contraindications

Clinical data states that pregnant and breastfeeding women are the primary excluded group. Although Calcium Hydroxylapatite (CaHA) itself is biocompatible, the initial clinical trial protocols did not include this group, resulting in a current lack of safety data regarding the preparation’s effect on fetal development or breast milk composition. Out of the precautionary principle, the common medical practice is to suggest this group postpone treatment. Additionally, high vigilance must be maintained for patients with a severe history of allergies or multiple allergy syndromes, especially those with documented allergies to Lidocaine. Radiesse preparations usually need to be mixed with 2% Lidocaine solution before use to reduce discomfort during injection. An allergic reaction could lead to severe local redness or even a systemic immune response.

Drug interference is the part of the pre-operative assessment with the highest data density. Patients taking anticoagulant medications or having coagulation disorders have a significantly increased probability of subcutaneous bruising and hematoma. Clinical statistics show that for subjects long-term taking Aspirin or Non-Steroidal Anti-Inflammatory Drugs (such as Ibuprofen, Naproxen), the proportion of bruising at the injection site is about 3.5 times higher than that of the general population.

To reduce the probability of post-operative complications, it is recommended that patients stop using all non-essential anticoagulant substances 7 to 14 days before injection. In addition to prescription drugs, many common nutritional supplements also have significant blood-thinning effects, including daily intakes of more than 400 IU of Vitamin E, more than 2000 mg of Deep Sea Fish Oil (Omega-3) daily, as well as St. John’s Wort, Ginkgo Biloba extract, and Ginseng. These components interfere with platelet aggregation and increase the risk of bleeding after the pierces a vessel. For patients who must take Warfarin or Clopidogrel due to cardiovascular disease, these deep tissue filling procedures should not be performed unless written permission is obtained from their specialist. The local skin environment of the injection area also plays a decisive role in safety. If there is active Herpes Simplex, acne inflammation, dermatitis, or any form of bacterial infection in and around the nasolabial fold, one must wait until the symptoms completely disappear and the skin barrier is repaired before proceeding.

Performing invasive injections in an infected area may bring surface pathogens into deep tissues, thereby inducing cellulitis or forming chronic Biofilms. Once the CaHA microsphere surface is colonized by bacteria, conventional antibiotic treatment is often difficult to clear completely, and may even lead to long-term redness and nodule formation.

Radiesse is prohibited from being injected into areas where permanent fillers (such as liquid silicone, PMMA particles, or polyacrylamide hydrogel) already exist. The meeting of substances with different chemical properties in the tissue may trigger complex delayed inflammatory reactions. Furthermore, if other types of bio-stimulants or large-molecule hyaluronic acid have been injected in the same area within the past 6 months, it is recommended to wait until the original substance is basically absorbed before proceeding, to avoid excessive tissue tension caused by volume stacking, thereby reducing the risk of local ischemia.

The time interval between dental surgery and facial injection is also often overlooked. Clinical advice is to avoid any invasive dental treatment, including cleaning, tooth extraction, or root canal therapy, within 2 weeks before and after receiving Radiesse injection.

Bacteria generated during dental procedures may migrate to the facial filler site through the circulatory system (i.e., transient bacteremia), increasing the probability of infection. In immunocompromised patient groups, such as those undergoing chemotherapy, taking immunosuppressants, or suffering from uncontrolled autoimmune diseases, the tissue response to microspheres may be unpredictable, and the healing process will be significantly prolonged. Such individuals have a statistically higher risk of forming fibrotic nodules after injection compared to healthy controls. Specific restrictions also exist for patients with long-distance flight plans in the near future. Due to air pressure changes and dry cabin environments during high-altitude flights, post-operative local edema may be aggravated. The medical community generally recommends avoiding flying within 48 to 72 hours after injection to ensure that the physical pressure on the tissue remains stable, allowing the CMC gel carrier to distribute evenly in the intended position.